Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway

Osteosarcoma is the frequent pediatric bone cancer where pediatric osteosarcoma incidences are more than 10% within the population. Most of the patients with osteosarcoma fall within the age of 15–30 years. Therefore, in this research, we examined the anticancer effect of Rhaponticin against the hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Mickymaray, Suresh, Alfaiz, Faiz Abdulaziz, Paramasivam, Anand, Veeraraghavan, Vishnu Priya, Periadurai, Nanthini Devi, Surapaneni, Krishna Mohan, Niu, Guangfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241634/
https://www.ncbi.nlm.nih.gov/pubmed/34220214
http://dx.doi.org/10.1016/j.sjbs.2021.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241634/
https://www.ncbi.nlm.nih.gov/pubmed/34220214
http://dx.doi.org/10.1016/j.sjbs.2021.05.006

Ejemplares similares